v1
Bleomycin, vincristine, and mitomycin C (BOM) as second-line treatment after failure of cis-platinum-based combination chemotherapy for recurrent cervical cancer.
Identifier:nobleid.org/w1/20260515/41234CEC
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/41234CEC)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims